EDGAR Filing Documents for 0001144204-13-042864

Form 8-K - Current report:

SEC Accession No. 0001144204-13-042864

Filing Date

2013-08-05

Accepted

2013-08-05 07:15:12

Documents

Period of Report

2013-08-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v351638_8k.htm	8-K	26662
2	EXHIBIT 10.1	v351638_ex10-1.htm	EX-10.1	178467
3	EXHIBIT 10.2	v351638_ex10-2.htm	EX-10.2	106923
4	EXHIBIT 10.3	v351638_ex10-3.htm	EX-10.3	51071
5	EXHIBIT 10.4	v351638_ex10-4.htm	EX-10.4	76370
6	EXHIBIT 99.1	v351638_ex99-1.htm	EX-99.1	14584
7	GRAPHIC	logo.jpg	GRAPHIC	4969
	Complete submission text file	0001144204-13-042864.txt		462488

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)